Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ADAPALENE DRUG SUBSTANCE, with a corresponding US DMF Number 19621.
Remarkably, this DMF maintains an Active status since its submission on July 10, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 12, 2014, and payment made on February 14, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II